Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial
Open Access
- 1 July 2015
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 78 (1) , 10-18
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major DepressionBiological Psychiatry, 2013
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On TrialBiological Psychiatry, 2012
- NMDA receptors and metaplasticity: Mechanisms and possible roles in neuropsychiatric disordersNeuroscience & Biobehavioral Reviews, 2012
- Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled StudyNeuropsychopharmacology, 2012
- Nitrous Oxide Anesthesia and Plasma Homocysteine in AdolescentsAnesthesia & Analgesia, 2011
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate AntagonistBiological Psychiatry, 2009
- Major Depressive DisorderNew England Journal of Medicine, 2008
- Antinociceptive Response to Nitrous Oxide Is Mediated by Supraspinal Opiate and Spinal α2Adrenergic Receptors in the RatAnesthesiology, 1996